Le Lézard
Classified in: Health, Science and technology
Subject: Personnel

Code Biotherapeutics Appoints Erin Brubaker as Chief Operating Officer


Code Biotherapeutics, Inc., a biotechnology company pioneering targeted non-viral delivery of genetic medicines, announces the appointment of Erin Brubaker as Chief Operating Officer, effective immediately.

"I am thrilled to welcome Erin to our Executive team," said Code Bio Chairman, Chief Executive Officer, and Co-Founder Brian P. McVeigh. "Erin's exceptional leadership skills, extensive experience developing strategy and driving operational excellence across corporate, R&D, and commercial organizations, expertise in integrating science and customer insights into commercial strategies that result in successful product launches, and her proven track record of developing high-performing teams will all serve Code Bio well as we continue to grow and advance our pipeline of important new genetic medicines for patients in need."

In her role as COO, Ms. Brubaker is leading corporate strategy and focusing on the buildout of the broader organization, with oversight of finance, manufacturing, human resources, information technology, legal, compliance, real estate and facilities, program and project management, corporate communications, and early commercial strategy.

Ms. Brubaker brings to this role extensive experience in the pharmaceutical and biotechnology industry including more than 20 years with GlaxoSmithKline Pharmaceuticals where she held positions of increasing responsibility enterprise-wide across R&D and commercial businesses. Most recently she served as Vice President Corporate Development at Passage Bio, a fully integrated gene therapy company.

"Code Bio has a unique opportunity to deliver targeted, non-viral gene therapies with its proprietary 3DNA delivery platform," said Ms. Brubaker. "It's a privilege to join the team and build the infrastructure that will enable delivery of the early pipeline in Duchenne Muscular Dystrophy and Type 1 Diabetes as well as enable future pipeline expansion into other rare and prevalent genetic diseases."

Ms. Brubaker holds a Bachelor of Arts from Franklin & Marshall College. She also completed the Transformational Leadership for Executives program through Wharton Business School at the University of Pennsylvania and holds professional certifications in Executive Coaching and Alliance Management. Ms. Brubaker is currently an Executive Board member for Life Sciences Pennsylvania.

About Code Biotherapeutics, Inc.

Headquartered in Greater Philadelphia, Code Bio is a next-generation genetic medicines company pioneering the development of targeted non-viral gene therapies to treat and potentially cure serious and life-threatening genetic diseases. Code Bio leverages its novel multivalent synthetic DNA delivery platform, 3DNA, which has been engineered to overcome many of the challenges inherent with viral-based gene therapies such as immunogenicity, size and delivery limitations, re-dosability, and manufacturing complexity. The Company is advancing an internal pipeline focused on select rare disease programs as well as establishing partnerships to take forward programs in both rare and prevalent diseases. For more information, visit www.codebiotx.com.


These press releases may also interest you

at 20:55
Leading impact intelligence platform HolonIQ today announced the appointment of Vernon Baxter as its Vice President, Health. "HolonIQ is the global authority on impact-focused and data-driven decision making and I am delighted to be joining the team...

at 20:45
Online On-demand Home Services Market in Malaysia Facts at a Glance- Total Pages: 120 Companies: 10+ ? ADVANCE DREAMS VENTURE Sdn...

at 20:05
WiSA, LLC, a wholly-owned subsidiary of Summit Wireless Technologies, Inc. , a leading provider of immersive, wireless sound technology for smart devices, will integrate WiSA's multichannel spatial audio capabilities into Realtek's 5GHz IoT chip...

at 20:05
Jio Haptik Technologies Limited, one of the world's largest conversational AI companies, today announced that RedDoorz, Southeast Asia's largest hotel management and booking platform, has selected Haptik to enhance its customer experience. RedDoorz...

at 20:00
International express logistics company J&T Express celebrated its second anniversary in Singapore on 9th January 2022, recording two years of exponential growth and progress, including a year-on-year double digit growth for parcel volumes, and an...

at 19:42
SK networks has been engaged in the mobility business through its affiliates 'SK Rent-a-Car' and car management brand 'SpeedMate', and is now making an investment in an EV infrastructure company to prepare for the era of home-based EV charging....



News published on 2 december 2021 at 08:35 and distributed by: